Parallel Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13
| Closed | -$278 | – | 3381 |
|
|
2023
Q2 | $278 | Buy |
+13
| New | +$278 | ﹤0.01% | 3201 |
|
|
2022
Q2 | – | Sell |
-164
| Closed | -$11K | – | 3058 |
|
|
2022
Q1 | $11K | Sell |
164
-587
| -78% | -$39.4K | ﹤0.01% | 1942 |
|
|
2021
Q4 | $56K | Sell |
751
-14
| -2% | -$1.04K | ﹤0.01% | 1250 |
|
|
2021
Q3 | $43K | Buy |
765
+667
| +681% | +$37.5K | ﹤0.01% | 1321 |
|
|
2021
Q2 | $4K | Buy |
98
+51
| +109% | +$2.08K | ﹤0.01% | 2332 |
|
|
2021
Q1 | $2K | Hold |
47
| – | – | ﹤0.01% | 2438 |
|
|
2020
Q4 | $2K | Sell |
47
-53
| -53% | -$2.26K | ﹤0.01% | 2275 |
|
|
2020
Q3 | $5K | Buy |
100
+65
| +186% | +$3.25K | ﹤0.01% | 1985 |
|
|
2020
Q2 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 2301 |
|
|
2018
Q2 | – | Sell |
-348
| Closed | -$28K | – | 2116 |
|
|
2018
Q1 | $28K | Buy |
+348
| New | +$28K | ﹤0.01% | 870 |
|